Feed aggregator

Whether people are mulling over the pros and cons of a purchase or assessing their interactions with new people, they may show a bias in placing more value on perceived positive or negative information.

We are all born completely helpless, with little of the knowledge and skills we will need to survive as adults. Even our ability to communicate is almost entirely learned from our parents or caregivers.

While they share similar depressive and cognitive symptoms, the biological underpinnings of bipolar disorder and major depressive disorder are distinct.

Infants exposed to certain environmental chemicals, including breast milk and everyday products such as personal care items, are more likely to have lower bone density in the first year of their lives, according to research presented at the 28th European Congress of Endocrinology in Prague.

Partners of women with gestational diabetes have more health-related risk factors and morbidity than partners of women without gestational diabetes.

New UCLA-led research finds that use of telemedicine has not significantly increased visits and medical spending across all payer types.

Among young adults with kidney failure, the expansion of Medicaid following the Affordable Care Act signed into law in 2010 was associated with substantial declines in one-year death rates, researchers from Brown University found in a new study.

Type 2 diabetes affects millions of people worldwide and now a new international study, jointly led by Adelaide University, University of Oxford, ETH Zurich, and Stanford University, has found one in ten people may not be benefiting from common medications used to treat the condition.

Stenotrophomonas maltophilia (S. maltophilia) is a multidrug-resistant bacterium that can cause severe and life-threatening hemorrhagic pneumonia in individuals with weakened immune systems.

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has established a Scientific Advisory Board (SAB) focused on pulmonary hypertension (PH).

Scientists at the University of East Anglia (UK) have contributed to discovering a "control switch" inside our immune cells that helps the body destroy dangerous fungal infections.

A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be doing more than causing discomfort.

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.

A new study by the Garvan Institute of Medical Research has uncovered a hidden mechanism explaining why breast cancer can return many years after successful treatment.

Findings indicate that elevated fine PM exposure before surgery correlates with higher postoperative complication rates, urging further research in this area.

The European Society of Cardiology identifies ultra-processed foods as a key cardiovascular risk, urging a shift in dietary guidelines for better heart health.

For babies born to people with endometriosis, there is a small but significant increased risk of congenital anomalies, often called birth defects, according to new research in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.250439.

An essay presented at this year's European Congress on Obesity in Istanbul, Turkey (12-15 May) suggests that new age of obesity drugs could shift the blame for living with obesity from individuals to the food industry – just as smoking has been blamed on tobacco industry and to a lesser extent alcohol consumption on the alcohol industry.

A new study presented at this year's European Congress on Obesity (ECO 2026) in Istanbul, Turkey (12-15 May) shows that a 1% reduction in annual working hours is associated with a 0.16% decrease in obesity rates across OECD countries.

A new analysis of the STEP trails carried out by semaglutide manufacturer Novo Nordisk has analysed various trials to show the safety and efficacy of the obesity drug semaglutide in older adults (over 65 years), and found similar efficacy and safety as in the general trial populations .